BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lucero MG, Dulalia VE, Parreno RN, Lim-Quianzon DM, Nohynek H, Makela H, Williams G. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. Cochrane Database Syst Rev 2004;:CD004977. [PMID: 15495133 DOI: 10.1002/14651858.CD004977] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Chowdhary S, Puliyel J. Incidence of pneumonia is not reduced by pneumococcal conjugate vaccine. Bull World Health Organ 2008;86:A; author reply A-C. [PMID: 18949200 DOI: 10.2471/blt.08.054692] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Loo JD, Conklin L, Fleming-Dutra KE, Deloria Knoll M, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia. Pediatr Infect Dis J 2014;33 Suppl 2:S140-51. [PMID: 24336056 DOI: 10.1097/INF.0000000000000082] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 7.4] [Reference Citation Analysis]
3 Conklin L, Loo JD, Kirk J, Fleming-Dutra KE, Deloria Knoll M, Park DE, Goldblatt D, O'Brien KL, Whitney CG. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children. Pediatr Infect Dis J 2014;33 Suppl 2:S109-18. [PMID: 24336053 DOI: 10.1097/INF.0000000000000078] [Cited by in Crossref: 60] [Cited by in F6Publishing: 35] [Article Influence: 7.5] [Reference Citation Analysis]
4 Jansen AG, Sanders EA, Hoes AW, van Loon AM, Hak E. Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial. J Pediatr 2008;153:764-70. [PMID: 18621393 DOI: 10.1016/j.jpeds.2008.05.060] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
5 Wiese AD, Griffin MR, Grijalva CG. Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States. Expert Rev Vaccines 2019;18:327-41. [PMID: 30759352 DOI: 10.1080/14760584.2019.1582337] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
6 Lucero MG, Dulalia VE, Nillos LT, Williams G, Parreño RA, Nohynek H, Riley ID, Makela H. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev 2009;:CD004977. [PMID: 19821336 DOI: 10.1002/14651858.CD004977.pub2] [Cited by in Crossref: 61] [Cited by in F6Publishing: 73] [Article Influence: 4.7] [Reference Citation Analysis]
7 Vila Córcoles A, de Diego Cabanes C, Salsench Serrano E, Saún Casas N. [Cover with conjugated heptavalent pneumoccal vaccine in the child population of Tarragona-Valls, Spain]. Aten Primaria 2007;39:507. [PMID: 17919406 DOI: 10.1157/13109503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Garcia Quesada M, Yang Y, Bennett JC, Hayford K, Zeger SL, Feikin DR, Peterson ME, Cohen AL, Almeida SCG, Ampofo K, Ang M, Bar-Zeev N, Bruce MG, Camilli R, Chanto Chacón G, Ciruela P, Cohen C, Corcoran M, Dagan R, De Wals P, Desmet S, Diawara I, Gierke R, Guevara M, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kleynhans J, Kristinsson KG, Ladhani SN, McGeer A, Mwenda JM, Nuorti JP, Oishi K, Ricketson LJ, Sanz JC, Savrasova L, Setchanova LP, Smith A, Valentiner-Branth P, Valenzuela MT, van der Linden M, van Sorge NM, Varon E, Winje BA, Yildirim I, Zintgraff J, Knoll MD, The Pserenade Team. Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project. Microorganisms 2021;9:738. [PMID: 33916227 DOI: 10.3390/microorganisms9040738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Toor J, Echeverria-Londono S, Li X, Abbas K, Carter ED, Clapham HE, Clark A, de Villiers MJ, Eilertson K, Ferrari M, Gamkrelidze I, Hallett TB, Hinsley WR, Hogan D, Huber JH, Jackson ML, Jean K, Jit M, Karachaliou A, Klepac P, Kraay A, Lessler J, Li X, Lopman BA, Mengistu T, Metcalf CJE, Moore SM, Nayagam S, Papadopoulos T, Perkins TA, Portnoy A, Razavi H, Razavi-Shearer D, Resch S, Sanderson C, Sweet S, Tam Y, Tanvir H, Tran Minh Q, Trotter CL, Truelove SA, Vynnycky E, Walker N, Winter A, Woodruff K, Ferguson NM, Gaythorpe KA. Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world. Elife 2021;10:e67635. [PMID: 34253291 DOI: 10.7554/eLife.67635] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Lee H, Nahm MH, Burton R, Kim KH. Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A. Clin Vaccine Immunol 2009;16:376-81. [PMID: 19144787 DOI: 10.1128/CVI.00344-08] [Cited by in Crossref: 56] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
11 Chang CC, Singleton RJ, Morris PS, Chang AB. Pneumococcal vaccines for children and adults with bronchiectasis. Cochrane Database Syst Rev 2009;:CD006316. [PMID: 19370631 DOI: 10.1002/14651858.CD006316.pub3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
12 Webster J, Theodoratou E, Nair H, Seong AC, Zgaga L, Huda T, Johnson HL, Madhi S, Rubens C, Zhang JS, El Arifeen S, Krause R, Jacobs TA, Brooks AW, Campbell H, Rudan I. An evaluation of emerging vaccines for childhood pneumococcal pneumonia. BMC Public Health 2011;11 Suppl 3:S26. [PMID: 21501444 DOI: 10.1186/1471-2458-11-S3-S26] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
13 Ewald H, Briel M, Vuichard D, Kreutle V, Zhydkov A, Gloy V. The Clinical Effectiveness of Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Dtsch Arztebl Int 2016;113:139-46. [PMID: 26987462 DOI: 10.3238/arztebl.2016.0139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
14 Obaro SK, Madhi SA. Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining? Lancet Infect Dis 2006;6:150-61. [PMID: 16500596 DOI: 10.1016/S1473-3099(06)70411-X] [Cited by in Crossref: 55] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]